This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

APO-VALPROIC ACID ORAL SOLUTION

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-VALPROIC ACID ORAL SOLUTION in Canada?

Yes. APO-VALPROIC ACID ORAL SOLUTION 250MG has an active shortage reported to Health Canada (last updated December 5, 2024).

Why is APO-VALPROIC ACID ORAL SOLUTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-VALPROIC ACID ORAL SOLUTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 3 same form & route

Affected strength250MG

Report last updated2023-11-02

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DEPAKENE

BGP PHARMA ULC

250MG · DIN 00443832

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-VALPROIC ACID

PHARMASCIENCE INC

250MG · DIN 02236807

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ODAN-VALPROIC ACID

ODAN LABORATORIESLTD

250MG · DIN 02549190

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

EPIVAL

BGP PHARMA ULC

250MG · DIN 00596426

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

APO-VALPROIC ACID

APOTEX INC

250MG · DIN 02238048

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MYLAN-DIVALPROEX

MYLAN PHARMACEUTICALS ULC

125MG · DIN 02458926

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02238370

Strength

250MG

Dosage Form

SOLUTION

Route

ORAL

Active Ingredient

VALPROIC ACID

Tier

Unrated

Last Updated

2023-11-02

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-VALPROIC ACID ORAL SOLUTION has 2 shortage/discontinuation reports on file — this is one of them.

2024-12-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244